S. Gail Eckhardt was named associate dean for experimental therapeutics and associate director for translational research at Baylor College of Medicine.
Phuong Gallagher and Mary McCabe have received the Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care from the National Coalition for Cancer Survivorship.
Three new officers were elected to ASTRO’s board of directors, including Sameer Keole, as president-elect; Wendy Woodward, as Science Council vice chair; and Vivek S. Kavadi, as Health Policy Council vice chair.
Nicholas Petrelli, Bank of America Endowed Medical Director of ChristianaCare’s Helen F. Graham Cancer Center & Research Institute received the Lifetime Achievement Award from Tulane University School of Medicine. Petrelli is a 1973 graduate of the school.
The American Society of Clinical Oncology was awarded $11 million in research funding by the Patient-Centered Outcomes Research Institute to study dosing strategies of oral CDK4/6 inhibitors in older adults living with metastatic breast cancer.
Researchers from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and Dana Farber Cancer Institute have received $7 million from the Patient-Centered Outcomes Research Institute to study how diet and exercise impact mental and physical functioning in older cancer survivors and their caregivers.
The University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute opened a new Radiation Oncology Center with expanded capabilities to provide advanced radiation treatments for children and adults with cancer, including the state’s first Proton Center.
FDA and CTTI announced a call for applications for new members of the Patient Engagement Collaborative. The PEC is an ongoing, shared forum in which the patient community (PEC members), FDA, and CTTI discuss a variety of topics such as improving communication, education, and patient engagement related to medical product regulation.
Carl H. June received the 2023 DKMS Mechtild Harf Science Award for his outstanding achievements in cancer immunology.
Julian Adams, an oncology researcher and retired pharmaceutical industry executive, was named chief science officer of Stand Up To Cancer.
